Invasive Ductal Carcinoma, Breast Clinical Trial
Official title:
Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer
This study will investigate the safety, feasibility, and immune response associated with
cryoablation of early invasive breast cancer prior to lumpectomy. Based on mouse models, the
investigators believe that cryoablation will initiate a stronger immune response relative to
the control group.
Consenting patients will be randomized to one of two arms: standard of care (control) or
cryoablation (intervention). Participants will undergo a blood draw at the time of consent.
Those in the control arm will continue with their standard of care lumpectomy. The
intervention arm will receive cryoablation 2 weeks before their scheduled lumpectomy and
undergo a second blood draw before the lumpectomy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04790305 -
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
|
Phase 4 | |
| Recruiting |
NCT04084730 -
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
|
Phase 2 |